Literature DB >> 12885285

Management of healthcare workers after occupational exposure to hepatitis C virus.

Patrick G P Charles1, Peter W Angus, Joseph J Sasadeusz, M Lindsay Grayson.   

Abstract

The increasing rate of hepatitis C virus (HCV) infection in the community means that there is increased risk of occupational exposure for healthcare workers. In metropolitan hospitals in Victoria, we found that 80-150 healthcare workers have occupational exposures from HCV-infected patients annually. As there is a 1.8%-3% risk of transmission of HCV from a needlestick injury, two to five healthcare workers are likely to acquire HCV each year in Victoria. These needlestick injuries pose a personal, legal and professional risk to healthcare workers and their patients. Recent information shows that early antiviral treatment of acute HCV infection has high cure rates. Current local and international protocols for management of healthcare workers exposed to HCV do not address these issues. We propose a management protocol after needlestick injury that is stratified according to the likelihood of HCV acquisition and potential risk of staff-to-patient transmission, and that is consistent with the current legal and clinical context of HCV infection in Australia.

Entities:  

Mesh:

Year:  2003        PMID: 12885285     DOI: 10.5694/j.1326-5377.2003.tb05475.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  3 in total

1.  Occupational blood and body fluid exposure in an Australian teaching hospital.

Authors:  P Bi; P J Tully; S Pearce; J E Hiller
Journal:  Epidemiol Infect       Date:  2005-09-30       Impact factor: 2.451

Review 2.  The unhealthy physician.

Authors:  Nicola Magnavita
Journal:  J Med Ethics       Date:  2007-04       Impact factor: 2.903

3.  Knowledge, attitudes and practice of Iranian medical specialists regarding hepatitis B and C.

Authors:  Ali Kabir; Seyed Vahid Tabatabaei; Siamak Khaleghi; Shahram Agah; Amir Hossein Faghihi Kashani; Mehrdad Moghimi; Fahimeh Habibi Kerahroodi; Seyed-E-Hoda Alavian; Seyed Moayed Alavian
Journal:  Hepat Mon       Date:  2010-09-01       Impact factor: 0.660

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.